anemarrhena asphodeloides

Condiciones de salud que anemarrhena asphodeloides puede ayudar a apoyar.

• DislocaciónCientífico

  Japanese clinical trials from the 1970s studied gamma oryzanol for gastrointestinal neurosis and autonomic nerve disorder-related digestive tract symptoms. Multiple peer-reviewed Japanese studies documented relief of heartburn, abdominal pain, and other GI complaints. The mechanism involves CNS modulation of digestive function.

• HipocondríaCientífico

  Gamma oryzanol is a well-documented antioxidant that scavenges reactive oxygen and nitrogen species (ROS/RNS) and activates the Nrf2 pathway, upregulating endogenous antioxidant enzymes including SOD and GPx. These effects have been confirmed in cell culture and animal models, and the antioxidant mechanism is central to many of its other documented health effects.

• Acidez EstomacalCientífico

  Animal studies show gamma oryzanol exerts anxiolytic effects by modulating the monoaminergic system in the amygdala. A 2020 PMC study found it alleviates high-fat-diet-induced anxiety-like behaviors through downregulation of dopamine and neuroinflammation. A separate restraint-stress study found decreased corticosterone via upregulation of the central monoaminergic system.

• Síndrome de Inmunodeficiencia AdquiridaCientífico

  Gamma oryzanol protects arterial health by suppressing endothelial NF-κB activation, reducing adhesion molecule expression, and combating endothelial senescence. Animal studies show a 67% reduction in aortic fatty streak formation. A 2025 study found gamma oryzanol ameliorates endothelial replicative senescence via SGLT2 downregulation and restoration of eNOS.

• Adicciones (drogas)Científico

  Human RCTs on gamma oryzanol for athletic performance show conflicting results. A 1997 double-blind RCT found 500 mg/day for 9 weeks had no effect on strength, performance, or anabolic hormone levels. A 2014 double-blind RCT found 600 mg/day increased muscular strength in bench press and leg curl despite no anthropometric change. Evidence is inconsistent.

• Fatiga SuprarrenalCientífico

  A 2025 systematic review of preclinical studies found gamma oryzanol exerts beneficial effects on glycaemic control by enhancing insulin secretion and sensitivity and reducing fasting blood glucose. A human clinical observation noted modest improvements in FBG and HbA1c. Preclinical mechanisms include AMPK activation and GLUT4 translocation.

• Válvula IleocecalCientífico

  Multiple clinical trials demonstrate that gamma oryzanol at 300 mg/day reduces total cholesterol and LDL-C in hypercholesterolemic patients. Mechanisms include inhibition of intestinal cholesterol absorption, increased bile acid conversion, and suppression of HMG-CoA reductase activity. HDL effects are mixed across studies. A randomized double-blind placebo-controlled study reported a 19.3% LDL-C reduction over three months.

• ApendicitisCientífico

  Gamma oryzanol suppresses NF-κB activation in vascular endothelial cells and macrophages, reducing pro-inflammatory cytokines. In human patients with type 2 diabetes, daily gamma oryzanol intake reduces circulating CRP, IL-6, and IFN-γ. Animal models confirm anti-inflammatory effects in colitis and obesity-related inflammation.

• Enfermedad del Hígado GrasoCientífico

  Gamma oryzanol has documented clinical use in Japan for chronic gastritis, with multiple 1970s–1980s Japanese clinical studies published in peer-reviewed pharmacology journals reporting symptom relief. It reduces post-meal GI symptoms including pain, nausea, and vomiting in gastritis patients, possibly by acting on CNS control of digestion and directly on the stomach.

• Moretones (prevención)Científico

  Gamma oryzanol has shown protective effects against diet-induced weight gain and obesity-associated metabolic dysfunction in animal models. Preclinical studies demonstrate reductions in body weight, visceral fat, and metabolic dysfunction markers. A 2025 review notes it ameliorates obesity-related metabolic disorders through improved skeletal muscle energy metabolism.

• JuanetesCientífico

  Gamma oryzanol supports heart health primarily through lipid lowering and vascular protective effects. It reduces adhesion molecule expression in vascular endothelium via NF-κB suppression, and animal data show it protects against structural and functional cardiac alterations induced by metabolic stress. It is approved in Japan for cardiovascular-related lipid management.

• Cáncer (prevención)Científico

  Japanese clinical trials beginning in the early 1960s demonstrated gamma oryzanol reduces hot flashes in menopausal and surgically postmenopausal women. In one study of 21 women given 300 mg/day for 38 days, more than 67% experienced a 50% or greater reduction in symptoms. The proposed mechanism involves suppression of LH secretion by the pituitary and stimulation of hypothalamic endorphin release.

• Olor de piesCientífico

  Gamma oryzanol improves insulin sensitivity through AMPK activation, GLUT4 translocation, and PPAR-α upregulation in preclinical models. A 2025 PMC review found clinical evidence supporting improved insulin sensitivity and glucose metabolism in metabolic syndrome patients. Animal studies demonstrate reduced HOMA-IR with supplementation.

• CóleraCientífico

  Gamma oryzanol has documented clinical use for menopausal symptom relief, particularly in Japan. Clinical trials show reductions in vasomotor symptoms, mood changes, and lipid abnormalities common in menopause. Its mechanism involves modulation of the hypothalamic-pituitary axis, reducing LH release and stimulating endorphin production.

• GingivitisCientífico

  Gamma oryzanol targets multiple components of metabolic syndrome—dyslipidemia, insulin resistance, obesity-related inflammation, and hyperglycemia—through several molecular pathways. Animal studies demonstrate protective effects against the full metabolic syndrome phenotype. A 2025 clinical review identifies emerging human evidence for its utility.

• Congestión (bronquial)Científico

  Gamma oryzanol's evidence for menopausal symptom relief extends to perimenopausal women undergoing the menopausal transition. A 2023 RCT (NCT05922800) specifically enrolled women during the menopausal transition period alongside postmenopausal women. Its hypothalamic-pituitary modulating effects are relevant during the perimenopausal hormonal fluctuation phase.

• Costra lácteaCientífico

  Gamma oryzanol has been investigated in cosmetic formulations for anti-aging effects on human skin. Studies on creams and gels containing gamma oryzanol and rice bran bioactive compounds showed promising results for amelioration of skin thickness, roughness, and elasticity. It also inhibits melanogenesis via tyrosinase inhibition and PKA-dependent pathways.

• Fibrosis QuísticaCientífico

  Gamma oryzanol reduces stress-induced physiological responses in animal models, including stress-induced gastric ulcers and elevated corticosterone. A 1984 PubMed-indexed study found it has antiulcerative action against gastric lesions induced by conditioned emotional stimuli and REM sleep deprivation. A restraint-stress study showed reduced HPA-axis activation.

• DebilidadCientífico

  Clinical studies show gamma oryzanol supplementation reduces serum triglyceride levels in hyperlipidemic patients. A review of trials suggests roughly 15% triglyceride reduction at 300 mg/day. Animal models show even larger effects. The mechanism involves PPAR-α activation and modulation of lipid metabolism pathways.

• Hernia HiatalCientífico

  Gamma oryzanol has demonstrated antiulcerative activity in both animal pharmacology studies and Japanese clinical practice. It inhibits stress-induced and ethanol-induced gastric ulcers through antioxidant and gastroprotective mechanisms. Japanese clinical papers from the 1970s document use in gastric and duodenal ulcers.

• HipotensiónTradicional

  Gamma oryzanol is used for high blood pressure in traditional and complementary medicine contexts, and it is listed among its uses on clinical reference sites. However, WebMD and EBSCO note there is no good scientific evidence supporting this use. One animal study in a metabolic syndrome model showed no significant effect on systolic blood pressure.

• Parálisis de BellTradicional

  Gamma oryzanol is used for eczema in complementary medicine contexts and is listed among its uses on clinical reference platforms. However, WebMD explicitly states there is no good scientific evidence to support this use, and no peer-reviewed clinical trials on eczema have been identified.

Sistemas corporales que anemarrhena asphodeloides puede ayudar a apoyar.

• No hay sistemas corporales disponibles.